Disease | liver cirrhosis |
Phenotype | C0019204|hepatocellular carcinoma |
Sentences | 74 |
PubMedID- 22666283 | Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma. |
PubMedID- 23769105 | Liver transplantation (lt) is a life-saving treatment for liver cirrhosis patients with hepatocellular carcinoma (hcc). |
PubMedID- 22363353 | Some individuals with persistent hcv infections develop liver cirrhosis, which can lead to hepatocellular carcinoma in some patients [1][2][3][4]. |
PubMedID- 25903707 | Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis. |
PubMedID- 24760057 | Biochemical nutritional profile of liver cirrhosis patients with hepatocellular carcinoma. |
PubMedID- 23146511 | Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient. |
PubMedID- 24223741 | Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis. |
PubMedID- 22523693 | These pleiotropic and highly variable functions go some way towards explaining the miscellany of associations that have been detected for vdr polymorphisms, among others with the occurrence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis, particularly in patients with an alcoholic etiology [30]. |
PubMedID- 25702281 | Serum paraoxonase 1 (pon1) is highly fucosylated in hepatocellular carcinoma (hcc) compared with liver cirrhosis (lc). |
PubMedID- 26116049 | Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis. |
PubMedID- 25091611 | hepatocellular carcinoma (hcc)-closely associated with liver cirrhosis and, in fact, the main cause of death in patients with such disease-is now recognized as one of the most-prevalent and lethal neoplasms worldwide. |
PubMedID- 22254115 | Chronic ethanol consumption causes changes in the liver, including fatty liver, inflammation and cirrhosis [179], and is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [180]. |
PubMedID- 20087783 | Background: the antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (hcc) in patients with liver cirrhosis. |
PubMedID- 23918576 | Patients were excluded for one of the following: 1) ascites due to liver cirrhosis with or without hepatocellular carcinoma, chronic renal failure, heart failure, or any malignancy other than epithelial ovarian cancer, 2) pregnancy, 3) previous history of malignancy or current evidence of any malignancy other than epithelial ovarian cancer, 4) recurred epithelial ovarian cancer or benign ovarian tumor, or 5) previous history of abdominal surgery. |
PubMedID- 26166077 | Magnetic resonance spectroscopy was used as a means of predicting the probability of developing hepatocellular carcinoma (hcc) in patients with liver cirrhosis secondary to chronic hepatitis b.this study included 20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis b (cirrhosis group), and 20 patients with small hcc secondary to cirrhosis liver parenchyma (hcc group). |
PubMedID- 25138286 | Purpose: the aim of this retrospective cohort study was to clarify the effect of a branched-chain amino acids (bcaa) on the liver function and the prognosis of child-pugh class (c-p) a and b liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc) undergoing hepatic arterial infusion chemotherapy (haic). |
PubMedID- 22346290 | A 44-year-old woman presented 3 years ago because of chronic hepatitis b-related liver cirrhosis with advanced multifocal hepatocellular carcinoma (hcc). |
PubMedID- 23316254 | Demonstrate that sorafenib-induced th1 dominance can prevent the escape of tumor cells from the host immune system in liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc). |
PubMedID- 25574115 | Twaij and colleagues have carried out a meta-analysis of cohort studies to review the currently available literature comparing laparoscopic to open resection of hepatocellular carcinoma in patients with known liver cirrhosis. |
PubMedID- 22606287 | Ald-associated disorders include fatty liver, inflammation, and hepatocellular carcinoma in patients with liver cirrhosis [41]. |
PubMedID- 22882828 | Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. |
PubMedID- 24229043 | A 69-year-old woman, who underwent cadaveric liver transplantation for non-b, non-c liver cirrhosis with hepatocellular carcinoma in april 2009, was admitted to our hospital because of graft dysfunction. |
PubMedID- 23320019 | In two studies performed on mrcc patients or liver cirrhosis patients with advanced hepatocellular carcinoma treated with sorafenib, no impact on th1 response has been observed [42, 44]. |
PubMedID- 21318009 | Moreover, chronic alcohol consumption is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [110]. |
PubMedID- 22483505 | The patient was a 62-year-old man, who suffered decompensated liver cirrhosis with hepatocellular carcinoma. |
PubMedID- 21388559 | In 40-60% of hcv-infected individuals, persistent infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [2,3]. |
PubMedID- 23372775 | In china, approximately 40 million people are infected with hcv [5], and it is estimated that 50% to 85% of all individuals infected with hcv develop chronic hepatitis; of these patients, 20% to 30% progress to liver cirrhosis that may lead to hepatocellular carcinoma (hcc). |
PubMedID- 25963079 | Using seldi-tof ms, serum protein/peptide profiles on the cm10 proteinchip arrays were obtained from a training group including 26 hbv-associated hepatocellular carcinoma patients with liver cirrhosis (lc), 30 hbv-associated lc patients, 85 patients at different stages of liver fibrosis, and 30 asymptomatic hbv carriers. |
PubMedID- 22776279 | Their perioperative course was favorable and comparable to that of other hepatocellular carcinoma patients with mild-moderate liver cirrhosis. |
PubMedID- 20345561 | Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. |
PubMedID- 23958083 | Background & aims: liver transplantation (lt) is a promising treatment for patients with liver cirrhosis associated with hepatocellular carcinoma (hcc). |
PubMedID- 23392977 | Impact of laparoscopic liver resection for hepatocellular carcinoma with f4-liver cirrhosis. |
PubMedID- 22504244 | We describe a well-differentiated hepatocellular carcinoma (hcc) with alcohol-related liver cirrhosis in a 69-year-old man. |
PubMedID- 20372847 | Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis. |
PubMedID- 25785114 | Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with hbv-associated liver cirrhosis in china. |
PubMedID- 25891119 | The present study examined the prognostic ability of our proposed performance status combined japan integrated staging (ps-jis) system in hepatocellular carcinoma (hcc) patients with liver cirrhosis (lc) comparing with other four prognostic systems including original jis system, the barcelona clinic liver cancer classification system, tnm classification system and the cancer of the liver italian program (clip) scoring system. |
PubMedID- 20736226 | Left atrial metastasis from hepatocellular carcinoma with liver cirrhosis. |
PubMedID- 20304209 | The best treatment for hepatocellular carcinoma (hcc) associated with liver cirrhosis is liver transplantation and the best results are obtained when the tumors fulfill the milan criteria. |
PubMedID- 26331402 | Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with child-pugh c liver cirrhosis. |
PubMedID- 26444667 | Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma. |
PubMedID- 23126044 | hepatocellular carcinoma mostly develops in patients with liver cirrhosis due to chronic hepatitis c virus (hcv) infection. |
PubMedID- 19345541 | Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. |
PubMedID- 19955816 | Impact of serial hepatitis b virus dna on hepatocellular carcinoma development in patients with liver cirrhosis. |
PubMedID- 25841913 | Management of liver cirrhosis in patients with hepatocellular carcinoma. |
PubMedID- 23690654 | These findings precluded the patient from resectional surgery on the basis of bilateral hepatocellular carcinoma with extensive liver cirrhosis. |
PubMedID- 22028976 | In hepatocellular carcinoma, all patients with liver cirrhosis or chronic hepatitis b virus infection are at risk. |
PubMedID- 21896165 | In 40-60% of hcv-infected individuals, chronic infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [3,4]. |
PubMedID- 21695929 | Its efficacy was shown in the sharp study that enabled licensing of sorafenib for the therapy of inoperable, metastasizing hepatocellular carcinoma, including patients with liver cirrhosis, functional class child-pugh a or b, in more than 60 countries worldwide, including the czech republic. |
PubMedID- 23708326 | Branched-chain amino acids (bcaas) reportedly inhibit the incidence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis and obesity that is frequently associated with insulin resistance (ir). |
PubMedID- 19701751 | Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis. |
Page: 1 2